Visit Booth #1534

We are looking forward to seeing you at the 2018 AABB Annual Meeting in Boston, Massachusetts.  Please take a moment to stop by the Grifols booth where you can learn more about the different solutions that we offer to help you work efficiently to deliver blood in safer and compatible manner for patients". Our transfusion medicine portfolio includes a range of blood testing and blood typing solutions.
 
The exhibition hours are as follows:  
 
Saturday, October 13 5:30 pm – 7:30 pm
Sunday, October 14 10:00 am – 4:30 pm
Monday, October 15 10:00 am – 4:30 pm
Tuesday, October 16 8:30 am – 11:00 am 

 

Products on Display

Screening

Our Procleix NAT solutions deliver high-quality, fully automated and integrated blood screening to your laboratories – from community blood centers to consolidated testing facilities around the world. With more worldwide placements than any other NAT provider, Procleix platforms screen more donors globally than any other NAT blood screening solution.1

The Procleix Panther system expands your laboratory's capabilities to anticipate the blood screening needs of today and tomorrow with a continuously expanding assay menu.

Smart design

  • Release first reportable results in 3.5 hours, then 5 additional results every 5 minutes
  • Features built-in process controls for sample and results integrity

 

Simple operation

  • Easy-to-use fully integrated and automated system
  • User-friendly software with a task-driven touchscreen interface

 

Versatile capabilities

  • Continuous or batch processing
  • Random access and STAT capabilities
Procleix Panther System

Typing

Grifols blood typing products cover the main demands of immunohematology laboratories, offering optimized technology for various testing needs and the expert support of a specialized global partner so that patients receive safer transfusions, right on time.

DG Gel system

Discover how the DG Gel system is continuously growing by offering increased adaptability and making daily work easier. With scalable systems that adapt to laboratories' different throughput and capacities while using the same reagents and equivalent software, users can select the solution that is best suited for their typing needs.

  • Designed to adapt to different workflow needs
  • Developed to provide intuitive operation in a compact footprint

 

A new perspective on conventional antisera:  Whether utilizing conventional reagents for all of your testing needs  or using antisera for resolving problematic cases, it is important to have  a wide range of conventional reagents to meet your needs. 

Grifols now offers a  wide range of monoclonal ABO  and Rh antisera, monoclonal rare antisera for extended phenotyping, anti-human globulin, internal quality controls and enhancement media.

The new Erytra Eflexis2: Adaptability that fits your lab

Introducing the new Erytra Eflexis – the natural evolution in Grifols scalable, blood typing solutions. This truly flexible system allows laboratories to select the solution that is best suited to different workflow needs and capacities.

The Erytra and Erytra Eflexis are true scalable systems that offer different throughput and capacities, while using the same reagents and sharing the equivalent software suite. Therefore you can select the solution that is best suited for your laboratory.

  • Smart
  • Flexible
  • Intuitive

 

Erytra system Erytra Eflexis system Wadiana System DG Reader


ID CORE XT3

The new ID CORE XT kit, part of the BLOODchip platform, provides extended blood group genotyping to support improved patient care.

  • Do more to prevent alloimmunization, even in your frequently transfused patients
  • Enhanced transfusion compatibility in patients with complex antibody profiles
  • Reduce the workload involved in complex antibody workups
  • Develop a more information-rich rare donor database to provide better-matched blood to the patients who need it most.

 

1 Grifols Diagnostic Solutions, Inc. Data on file. June 2018

2 The Erytra Eflexis analyzer is CE marked in accordance with the Directive EC of the European Parliament and of the Council of October on in vitro diagnostic medical devices. This product is not available for commercial sale in the United States. It is intended for healthcare professionals only. Product registration and availability vary by country. To know whether the Erytra Eflexis system is available for sale in your country, please contact your local Grifols representative.

3 ID CORE XT is CE marked and in the US, is for research use only and not for use in diagnostic procedures.

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.

Grifols Immunohematology Center & Clinical Laboratory

Grifols Immunohematology Center

Deliver improved patient care and enhance the efficiency of your laboratory with extended testing capabilities.  Our CAP certified laboratory at the Grifols Immunohematology Center provides testing and support for the most challenging cases, saving you time and resources that would otherwise be consumed by complex workups.

The Grifols Immunohematology Center gives you the tools to:

  • Improve patient outcomes by providing better matched blood faster
  • Reduce costs and enhance efficiency in the blood bank and at the bedside
  • Strengthen your expertise with our advanced consulting and continuing education opportunities


Grifols Clinical Laboratory

Our lab offers specialized testing panels for selected medical needs like therapeutic drug monitoring and diagnosis of different genetic diseases like familial hypercholesterolemia (FH).

TDMonitor is a new panel of assays to measure levels of Infliximab (Remicade, Inflectra, Remsima), Adalimumab (Humira) or Vedolizumab (Entyvio) and the anti-drug antibodies. Test results support clinicians, hospitals, and laboratories, globally, in making therapeutic decisions, improving patient therapy strategy and reducing the risk of debilitating disease progression. TDMonitor assays were developed and validated by Grifols CLIA-certified Clinical Laboratory in San Marcos, Texas. Samples may be mailed to the Texas laboratory. Following testing of the sample, a complete report, that includes recommendations with references, is generated and then submitted to the health care provider in 5-7 days.

Grifols offers genetic tests to diagnose familial hypercholesterolemia (FH) by using the advanced sequencing technologies. FH is a condition present in 1 in 250 people worldwide. This genetic condition causes lifelong levels of high cholesterol, which can lead to early coronary artery disease.

Scientific Corner

Grifols is committed to research and development supporting scientific initiatives. Our Scientific Corner is the Grifols knowledge hub to discuss scientific topics in transfusion medicine.

Grifols is committed to research and development supporting scientific initiatives. Our Scientific Corner is the Grifols knowledge hub to discuss scientific topics in transfusion medicine.

In the Scientific Corner you will have the opportunity to explore all the scientific and educational materials developed by Grifols in the transfusion medicine field and access digital copies of those of interest.

You will also have the opportunity to meet with our medical affairs team members, ready to address your scientific and technical concerns.

Come to find out what's new with:

  • Emerging infectious diseases
  • Anti-CD38 and other monoclonal antibodies